InvestorBrandNetwork (IBN) logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Refocuses R&D Portfolio on NanoAb Platform and CDMO Growth

September 8, 2026Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company combining immunology therapeutic development with a revenue-generating contract development and manufacturing organization (“CDMO”), announced a strategic refocusing of its R&D portfolio following the Aug. 31 expiration and termination of its option and license arrangements with PinCell S.


TechMediaBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) Showcases Neural Sensing Technology for Physical AI and Humanoid Robotics

September 8, 2026Wearable Devices (NASDAQ: WLDS), a pioneer in artificial intelligence (“AI”)-powered touchless sensing wearables, announced that it will showcase its neural sensing layer for Physical AI and humanoid robotics at Physical AI 2026 in Tel Aviv. The company technology is designed to complement vision-based training data with synchronized signals associated with human movement, muscle activation and intent.


Cyabra Inc. (NASDAQ: CYAB) Featured in Coverage of the Disruptive Growth & Life Sciences Conference

September 8, 2026Cyabra (NASDAQ: CYAB) is an AI-powered narrative intelligence company that helps national security and defense organizations, government agencies, brands, communications agencies, and global enterprises restore trust and authenticity online by analyzing manipulated content, coordinated behaviors, and inauthentic actors. The platform helps teams understand who is operating, how activity is amplified, and where coordinated activity is shaping perception, translating evidence into clear mitigation steps.


A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach

September 8, 2026BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) drugs on the market today can slow the disease down, but none of them stop it, and none of them give patients back what they have already lost. Nearly one million people in the United States, and close to 2.


South African Platinum Miner Pays Out Millions in Dividends

September 8, 2026Impala Platinum, a South African giant in the global PGM industry, has paid out enhanced dividends to its shareholders after enjoying a year of bulked-up metal prices as PGMs saw their prices soar in a reversal of multiple years of dismal prices. Analysts are watching to see how other major platinum producers like Platinum Group Metals Ltd.


A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach

September 8, 2026BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) drugs on the market today can slow the disease down, but none of them stop it, and none of them give patients back what they have already lost. Nearly one million people in the United States, and close to 2.


NetworkNewsBreaks – NanoViricides (NYSE American: NNVC) Registers Phase II Ebola Trial for NV-387 Oral Gummies

September 8, 2026NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage developer of antiviral drugs, announced that its phase II clinical trial evaluating NV-387 Oral Gummies as a treatment for Bundibugyo ebolavirus and other Ebola viruses in the Democratic Republic of Congo (“DRC”) has been registered in the Pan African Clinical Trials Registry under identification number PACTR202608748555077.


InvestorNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML) Sets Q4 Biotech Spin-Off as Company Sharpens Critical Minerals Focus

September 8, 2026Greenland Mines (NASDAQ: GRML) announced a series of corporate milestones as it transitions into a focused rare earths and critical minerals company, including plans to spin off its biotechnology division in the fourth quarter of 2026. Nasdaq has formally approved the company application relating to its March 2026 transaction, resolving prior deficiencies and bringing Greenland Mines into full compliance with listing requirements.